meRfi®-GM
Liver Fibrosis / Cirrhosis
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Liver cirrhosis is common worldwide and can have various causes:
- Adiposity / obesity,
- non-alcoholic fatty liver disease,
- high alcohol consumption,
- hepatitis B or C infection,
- autoimmune diseases,
- cholestatic diseases, and
- iron or copper overload.
Liver fibrosis is the primary determinant of liver dysfunction and mortal…
References (Sources)
- Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index
- Lack of effect of norfloxacin on hyperdynamic circulation in bile duct-ligated rats despite reduction of endothelial nitric oxide synthase function: result of unchanged vascular Rho-kinase?
- NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice
- Progression of stage 2 and 3 acute kidney injury in patients with decompensated cirrhosis and ascites
- Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis
- The hyperdynamic circulation in cirrhosis: an overview
- Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis